Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of11C-methionine positron emission tomography

Journal of Neurosurgery

Volumn 114, Issue 6, 2011, Pages 1640-1647

  Shinozaki, Natsuki ^a   Uchino, Yoshio ^b   Yoshikawa, Kyosan ^c   Matsutani, Tomoo ^a   Hasegawa, Azusa ^c   Saeki, Naokatsu ^a   Iwadate, Yasuo ^a,c  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Chiba Medical Center for Prolonged Traumatic Brain Dysfunction   (Japan)

^c NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

1p 19q deletion; Glioma; Methionine; Oligodendroglial tumor; Positron emission tomography

Indexed keywords

CARBON 11; METHIONINE; MONOCLONAL ANTIBODY KI 67;

ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CANCER SURVIVAL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TUMOR CLASSIFICATION;

ADULT; AGED; ANALYSIS OF VARIANCE; ASTROCYTOMA; BRAIN NEOPLASMS; CARBON RADIOISOTOPES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; OLIGODENDROGLIOMA; POSITRON-EMISSION TOMOGRAPHY;

EID: 79957973211     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2010.11.JNS10553     Document Type: Article

References (30)

1. Bading JR, Kan-Mitchell J, Conti PS: System A amino acid transport in cultured human tumor cells: implications for tumor imaging with PET. Nucl Med Biol 23:779-786, 1996 (Pubitemid 26342482)
2. Behin A, Hoang-Xuan K, Carpentier AF, Delattre JY: Primary brain tumours in adults. Lancet 361:323-331, 2003 (Pubitemid 36126198)
3. Braun V, Dempf S, Weller R, Reske SN, Schachenmayr W, Richter HP: Cranial neuronavigation with direct integration of (11)C methionine positron emission tomography (PET) data - results of a pilot study in 32 surgical cases. Acta Neurochir (Wien) 144:777-782, 2002
4. Bromberg JEC, van den Bent MJ: Oligodendrogliomas: molecular biology and treatment. Oncologist 14:155-163, 2009
5. Ceyssens S, Van Laere K, de Groot T, Goffin J, Bormans G, Mortelmans L: [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. AJNR Am J Neuroradiol 27:1432-1437, 2006 (Pubitemid 44260122)
6. 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging 29:176-182, 2002
7. De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, et al: Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 95:746-750, 2001 (Pubitemid 33043345)
8. Durand KS, Guillaudeau A, Weinbreck N, DeArmas R, Robert S, Chaunavel A, et al: 1p19q LOH patterns and expression of p53 and Olig2 in gliomas: relation with histological types and prognosis. Mod Pathol 23:619-628, 2010
9. Gan HK, Rosenthal MA, Dowling A, Kalnins R, Algar E, Wong N, et al: A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors. Neuro Oncol 12:500-507, 2010
10. Giannini C, Burger PC, Berkey BA, Cairncross JG, Jenkins RB, Mehta M, et al: Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402. Brain Pathol 18:360-369, 2008 (Pubitemid 351782844)
11. Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, et al: Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy. Cancer 78:1098-1106, 1996
12. Higuchi Y, Iwadate Y, Yamaura A: Treatment of low-grade oligodendroglial tumors without radiotherapy. Neurology 63:2384-2386, 2004 (Pubitemid 40024356)
13. Iuchi T, Iwadate Y, Namba H, Osato K, Saeki N, Yamaura A, et al: Glucose and methionine uptake and proliferative activity in meningiomas. Neurol Res 21:640-644, 1999 (Pubitemid 29510832)
14. Iwadate Y, Sakaida T, Hiwasa T, Nagai Y, Ishikura H, Takiguchi M, et al: Molecular classification and survival prediction in human gliomas based on proteome analysis. Cancer Res 64:2496-2501, 2004 (Pubitemid 38523905)
15. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA: Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 42:432-445, 2001 (Pubitemid 32207394)
16. Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Del Fiore G, et al: Preoperative evaluation of 54 gliomas by PET with fluorine-18- fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 39:778-785, 1998 (Pubitemid 28216722)
17. Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, et al: Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol 29:1176-1182, 2008 (Pubitemid 351954890)
18. Kim S, Chung JK, Im SH, Jeong JM, Lee DS, Kim DG, et al: 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging 32:52-59, 2005 (Pubitemid 40142778)
19. Kondziolka D, Lunsford LD, Martinez AJ: Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 79:533-536, 1993 (Pubitemid 23289810)
20. Kracht LW, Friese M, Herholz K, Schroeder R, Bauer B, Jacobs A, et al: Methyl-[11C]- l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 30:868-873, 2003 (Pubitemid 36734206)
21. Kracht LW, Miletic H, Busch S, Jacobs AH, Voges J, Hoevels M, et al: Delineation of brain tumor extent with [11C]L-methionine positron emission tomography: local comparison with stereotactic histopathology. Clin Cancer Res 10:7163-7170, 2004
22. Kubota K: From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology. Ann Nucl Med 15:471-486, 2001
23. Lebrun C, Fontaine D, Bourg V, Ramaioli A, Chanalet S, Vandenbos F, et al: Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapy. Eur J Neurol 14:391-398, 2007 (Pubitemid 46481159)
24. 11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 103:498-507, 2005
25. Ogawa T, Kanno I, Hatazawa J, Inugami A, Fujita H, Shimosegawa E, et al: Methionine PET for follow-up of radiation therapy of primary lymphoma of the brain. Radiographics 14:101-110, 1994
26. Okita Y, Kinoshita M, Goto T, Kagawa N, Kishima H, Shimosegawa E, et al: (11)C-methionine uptake correlates with tumor cell density rather than with microvessel density in glioma: a stereotactic image-histology comparison. Neuroimage 49:2977-2982, 2010
27. Ribom D, Eriksson A, Hartman M, Engler H, Nilsson A, Långström B, et al: Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. Cancer 92:1541-1549, 2001 (Pubitemid 32947840)
28. Singhal T, Narayanan TK, Jain V, Mukherjee J, Mantil J: 11C-L-methionine positron emission tomography in the clinical management of cerebral gliomas. Mol Imaging Biol 10:1-18, 2008
29. Souba WW, Pacitti AJ: How amino acids get into cells: mechanisms, models, menus, and mediators. JPEN J Parenter Enteral Nutr 16:569-578, 1992
30. Wessels PH, Weber WE, Raven G, Ramaekers FC, Hopman AH, Twijnstra A: Supratentorial grade II astrocytoma: biological features and clinical course. Lancet Neurol 2:395-403, 2003 (Pubitemid 36793931)